What is the significance of an accidental intramuscular (IM) injection of 2 milliliters (mL) of lidocaine (0.1% solution)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the FDA Drug Label

The lowest dosage that results in effective anesthesia should be used to avoid high plasma levels and serious adverse effects. Repeated doses of lidocaine HCl may cause significant increases in blood levels with each repeated dose because of slow accumulation of the drug or its metabolites. It should be kept in mind at such times that restlessness, anxiety, tinnitus, dizziness, blurred vision, tremors, depression or drowsiness may be early warning signs of central nervous system toxicity.

The significance of accidentally injecting 2 ml of lidocaine 0.1% intramuscularly (IM) is that it may cause central nervous system toxicity or other adverse effects. The FDA drug label recommends using the lowest dosage that results in effective anesthesia to avoid high plasma levels and serious adverse effects. However, the label does not provide a specific dosage limit for a single accidental injection.

  • Key considerations:
    • Dose and concentration: The actual volume and concentration used depend on factors like the type and extent of the procedure, depth of anesthesia, and patient condition.
    • Patient condition: Dosages should be reduced for children, the elderly, debilitated patients, and those with cardiac and/or liver disease.
    • Monitoring: Careful and constant monitoring of cardiovascular and respiratory vital signs and the patient's state of consciousness is necessary after each local anesthetic injection. 1 1 1

From the Research

Accidental intramuscular injection of 2 ml of lidocaine 0.1% is generally not clinically significant. This dose contains only 2 mg of lidocaine (0.1% means 1 mg/ml), which is well below the toxic threshold, as noted in a case report on local anesthetic systemic toxicity 2. For context, therapeutic doses of lidocaine for local anesthesia typically range from 20-200 mg, and toxicity usually occurs at much higher doses (>300 mg in adults) 3. The small amount injected would be absorbed gradually from muscle tissue and metabolized by the liver without causing systemic effects. Patients may experience mild local effects like temporary numbness or discomfort at the injection site. However, if the patient shows any unusual symptoms such as dizziness, ringing in the ears, metallic taste, confusion, or cardiac arrhythmias (which would be extremely unlikely at this dose), medical attention should be sought. Individuals with severe liver disease or certain cardiac conditions might be more sensitive to even small amounts of lidocaine, but this dose remains minimal for almost all patients.

Some key points to consider in the use of local anesthetics include the potential for local anesthetic systemic toxicity (LAST), which can affect the cardiac and central nervous systems, and the importance of healthcare providers being trained in LAST treatment and prevention 2. Additionally, the dosage of local anesthetics should be adjusted in certain populations, such as children, elderly, and fragile individuals, and those with organ failures, as their metabolism of the compounds may be impaired 3.

In terms of management, intravenous lipid emulsion is an important life-saving treatment in severe, life-threatening cases of LAST 3. It is also essential to recognize the signs and symptoms of LAST, which can range from mild findings, such as temporary hypertensive events, to serious conditions, including refractory cardiac dysfunction, dysrhythmias, and prearrest situations 3.

Overall, while accidental intramuscular injection of 2 ml of lidocaine 0.1% is not expected to cause significant harm, it is crucial to be aware of the potential risks and take steps to prevent and manage any adverse effects that may occur.

Related Questions

What is the likelihood of local anesthetic systemic toxicity (LAST) in a 77.2 Kg patient administered 36cc's of lidocaine (local anesthetic) without epinephrine (adrenergic receptor agonist) over 3 hours?
What is the likelihood of developing lidocaine (local anesthetic) toxicity in a 72.72 kg patient who received 3cc's of 1% lidocaine (local anesthetic) without epinephrine (adrenergic receptor agonist) and 30cc's of 2% lidocaine (local anesthetic) without epinephrine (adrenergic receptor agonist) over 3 hours for local anesthesia?
What is the risk of local anesthetic systemic toxicity (LAST) in a 72.72 Kg adult patient who received 3cc's of 1% lidocaine (lidocaine) with epinephrine (epinephrine) + 6cc's of 2% lidocaine (lidocaine) without epinephrine (epinephrine) in the first hour, followed by 24cc's of 2% lidocaine (lidocaine) without epinephrine (epinephrine) over the next 2 hours?
What is the likelihood of Local Anesthetic Systemic Toxicity (LAST) in a 77.2kg patient administered 36cc's of 2% lidocaine (local anesthetic) without epinephrine (adrenergic receptor agonist) over 3 hours?
What is the effect of injecting 2 milliliters (mL) of lidocaine (0.1% solution)?
What value act should be run during cardiopulmonary bypass (CPB)?
What adjustments can be made to the treatment regimen of a 2-year-old female patient with stage 2 hypertension, currently on Losartan (Angiotensin II Receptor Antagonist) 25mg daily and Propranolol (Beta Blocker) 20mg twice weekly, who remains hypertensive with bradycardia?
What can be done to improve stage 2 hypertension in a 72-year-old female patient on losartan (angiotensin II receptor antagonist) 25mg daily and propranolol (beta blocker) 20mg twice weekly, with bradycardia (heart rate in the high 40s to low 50s)?
What is the cause of anaphylaxis during type O, Rh-negative packed red blood cells (RBCs) transfusion in a patient with ruptured ectopic pregnancy?
What is the cause of the patient's left ear fullness and sensation of dry skin inside the ear?
Is Parvovirus (B19) susceptible to antimicrobial therapy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.